Cargando…

Barriers and solutions to Alzheimer's disease clinical trial participation for Black Americans

INTRODUCTION: Black Americans are disproportionately burdened by Alzheimer's disease (AD) relative to other racial groups in the United States and continue to be underrepresented in AD clinical trials. This review explores the primary barriers for participation in clinical trials among Black Am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Savold, Jordan, Cole, Michele, Thorpe, Roland J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318422/ https://www.ncbi.nlm.nih.gov/pubmed/37408664 http://dx.doi.org/10.1002/trc2.12402

Ejemplares similares

Factors influencing the participation of Black and White Americans in Alzheimer's disease biomarker research
por: Eliacin, Johanne, et al.
Publicado: (2022)

Barriers and facilitators to participating in Alzheimer's disease biomarker research in black and white older adults
por: Eliacin, Johanne, et al.
Publicado: (2023)

African American participation in cancer clinical trials
por: Swaby, Jordan, et al.
Publicado: (2021)

Psychological well-being and cognitive aging in Black, Native American, and White Alzheimer’s Disease Research Center participants
por: Wyman, Mary F., et al.
Publicado: (2022)

Older Black Americans and Depressive Symptoms During the COVID-19 Pandemic
por: Chae, David, et al.
Publicado: (2021)

177 Education and Its Effects on Barriers to Clinical Trial Participation in Alzheimer’s Disease Studies by Underrepresented Communities
por: Ziegler, Mallory, et al.
Publicado: (2023)

Mitochondrial disease patient motivations and barriers to participate in clinical trials
por: Zolkipli-Cunningham, Zarazuela, et al.
Publicado: (2018)

LOCI RESPONSIBLE FOR RACIAL DISPARITY BETWEEN WHITE AND BLACK AMERICANS IN ALZHEIMER’S DISEASE
por: Nikitin, Stanislav Kolpakov, et al.
Publicado: (2022)

Modifiable Barriers for Recruitment and Retention of Older Adults Participants from Underrepresented Minorities in Alzheimer’s Disease Research
por: Indorewalla, Khushnoo K., et al.
Publicado: (2021)

Addressing multilevel barriers to clinical trial participation among Black and White men with prostate cancer through the PACCT study
por: Eggly, Susan, et al.
Publicado: (2022)

Using Community Health Workers to Address Barriers to Participation and Retention in Diabetes Prevention Program: A Concept Paper
por: Zare, Hossein, et al.
Publicado: (2022)

Mitochondrial DNA oxidative mutations are elevated in Mexican American women potentially implicating Alzheimer’s disease
por: Reid, Danielle Marie, et al.
Publicado: (2022)

Barriers to accrue to clinical trials and possible solutions
por: Winters, Z E, et al.
Publicado: (2014)

Effect of Age on Clinical Trial Outcome in Participants with Probable Alzheimer’s Disease
por: Targum, Steven D., et al.
Publicado: (2021)

The Role of Social Support in Cardiovascular Clinical Trial Participation among Black Men: Black Impact
por: Addison, Sarah, et al.
Publicado: (2022)

Recruitment and retention of the participants in clinical trials: Challenges and solutions
por: Chaudhari, Nayan, et al.
Publicado: (2020)

Identifying Facilitators and Barriers to Increasing COVID-19 Vaccination and Trial Participation in Vaccinated Vietnamese Americans
por: Nguyen, Celine, et al.
Publicado: (2022)

Barriers to Clinical Trial Participation: Comparative Study Between Rural and Urban Participants
por: Mudaranthakam, Dinesh Pal, et al.
Publicado: (2022)

Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias in African Americans: Focus on Caregivers
por: Kopel, Jonathan, et al.
Publicado: (2023)

The blood-brain barrier in Alzheimer's disease
por: Zenaro, Elena, et al.
Publicado: (2017)

Inclusion of African American/Black adults in a pilot brain proteomics study of Alzheimer’s disease
por: Stepler, Kaitlyn E., et al.
Publicado: (2020)

Assessing Multiple Factors Affecting Minority Participation in Clinical Trials: Development of the Clinical Trials Participation Barriers Survey
por: Allison, Karen, et al.
Publicado: (2022)

Genetics of Alzheimer’s Disease in the African American Population
por: Logue, Mark W., et al.
Publicado: (2023)

African Americans are less likely to enroll in preclinical Alzheimer's disease clinical trials
por: Zhou, Yan, et al.
Publicado: (2016)

Globalization of Alzheimer's disease clinical trials
por: Cummings, Jeffrey, et al.
Publicado: (2011)

Black Americans
Publicado: (1970)

Racism and Older Black Americans’ Health: a Systematic Review
por: LaFave, S. E., et al.
Publicado: (2022)

Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation
por: Unger, Joseph M, et al.
Publicado: (2019)

Annual Review of Gerontology and Geriatrics Symposium: Black Older Adults in the Era of Black Lives Matter
por: Kelley, Jessica, et al.
Publicado: (2021)

Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews
por: Rodríguez-Torres, Edgardo, et al.
Publicado: (2021)

Blood–brain-barriers in aging and in Alzheimer’s disease
por: Marques, Fernanda, et al.
Publicado: (2013)

Dietary Polyphenols and the Risk of Alzheimer's Disease and Related Dementias Among Low-income Black and White Americans
por: Yang, Jae Jeong, et al.
Publicado: (2022)

Healthy Lifestyles and the Risk of Alzheimer's Disease and Related Dementias among Low-Income Black and White Americans
por: Yu, Danxia, et al.
Publicado: (2022)

Mexican-American perspectives on participation in clinical trials: A qualitative study
por: Arevalo, Mariana, et al.
Publicado: (2016)

American Ginseng for the Treatment of Alzheimer’s Disease: A Review
por: Shan, Mengyao, et al.
Publicado: (2023)

Psychometric Properties and Analysis of the Masculinity Barriers to Medical Care Scale Among Black, Indigenous, and White Men
por: Rogers, Charles R., et al.
Publicado: (2021)

Advancing Alzheimer’s Disease Care and Services Among Racial and Ethnic Minorities
por: Smith, Lenora, et al.
Publicado: (2020)

Imaging endpoints for clinical trials in Alzheimer’s disease
por: Cash, David M, et al.
Publicado: (2014)

Drug candidates in clinical trials for Alzheimer’s disease
por: Hung, Shih-Ya, et al.
Publicado: (2017)

Clinical trials of new drugs for Alzheimer disease
por: Huang, Li-Kai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hkass9p5cfdn2kqkrplkepihot